BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/10/2014 3:50:00 PM | Browse: 1877 | Download: 1997
 |
Received |
|
2014-05-22 09:21 |
|
Peer-Review Started |
|
2014-05-22 13:30 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-06-20 15:02 |
|
Revised |
|
2014-07-23 01:24 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-10-15 12:33 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-10-15 17:43 |
|
Articles in Press |
|
2014-10-15 17:57 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-11-20 18:51 |
|
Publish the Manuscript Online |
|
2014-12-10 15:52 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Pharmacologic therapy for acute pancreatitis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Swetha Kambhampati, Walter Park and Aida Habtezion |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Aida Habtezion, MD, Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, United States. aidah@stanford.edu |
| Key Words |
Acute pancreatitis; Antisecretory; Protease inhibitors; Anti-inflammatory; Anti-oxidants; Systemic inflammatory response syndrome; Organ failure; Mortality |
| Core Tip |
Currently there are no approved therapies for acute pancreatitis. This review summarizes and discusses pre-clinical and clinical studies in acute pancreatitis and also discusses potential promising therapies. |
| Publish Date |
2014-12-10 15:52 |
| Citation |
Kambhampati S, Park W, Habtezion A. Pharmacologic therapy for acute pancreatitis. World J Gastroenterol 2014; 20(45): 16868-16880 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i45/16868.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i45.16868 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
